N,n'-dimethylethylenediaminediacetic acid | 114936-86-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N,n'-dimethylethylenediaminediacetic acid
• 英文别名: 2-[Carboxymethyl-[2-(dimethylamino)ethyl]amino]acetic acid
• CAS: 114936-86-6
• 化学式: C₈H₁₆N₂O₄
• 分子量: 204.226
• InChiKey: XLQGOLQGWSEWTE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -5.1
• 重原子数：
  14
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  81.1
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Diagnostic Agents Selective Against Metalloproteases
  申请人：Rossello Armando

  公开号：US20110117015A1

  公开（公告）日：2011-05-19

  The invention relates to aryl-sulphonamido compounds endowed with affinity against metallo proteases MMP, having formula (I) below wherein R, R 1 , R 2 , R 3 , G and n have the meanings reported in the specification, properly labelled with diagnostic imaging moieties or even radiotherapeutic moieties. The invention also refers to the process for their preparation, to pharmaceutical compositions comprising them and to their use as diagnostic imaging agents or radiotherapeutic agents.
• VINYL MONOMERS HAVING CHELATING FUNCTIONALITY
  申请人：Dow Global Technologies LLC

  公开号：US20140303397A1

  公开（公告）日：2014-10-09

  The present invention provides novel polymerizable monomers having chelating functionality and processes to make them. In particular, the novel monomers are ethylenically unsaturated aminocarboxylates and are prepared by reacting ethylenediamine triacetic acid or its salt with an ethylenically unsaturated monomer. The ethyleneically unsaturated monomer may be a polymerizable vinyl monomer selected from (o-, p-, m-)DVBMO, allyl glycidyl ether, and glycidyl (meth)acrylate.
• LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
  申请人：ALNYLAM PHARMACEUTICALS, INC.

  公开号：US20140308304A1

  公开（公告）日：2014-10-16

  The present invention relates to novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides, to facilitate the cellular uptake and endosomal escape, and to knockdown target mRNA both in vitro and in vivo. The invention also relates to lipid particles comprising a neutral lipid, a lipid capable of reducing aggregation, a cationic lipid of the present invention, and optionally, a sterol. The lipid particle may further include a therapeutic agent such as a nucleic acid.
• POLYMERS HAVING CHELATING FUNCTIONALITY
  申请人：Dow Global Technologies LLC

  公开号：US20140303337A1

  公开（公告）日：2014-10-09

  The present invention provides novel polymers having chelating functionality and comprising units derived from an ethylenically unsaturated aminocarboxylate monomer which comprises units derived from ethylenediamine triacetic acid or its salt and a polymerizable vinyl monomer. The polymerizable vinyl monomer may be selected from (0-, m-, p-)DVBMO, allyl glycidyl ether, and glycidyl (meth)acrylate. The polymer may also comprise units derived from one or more ethylenically unsaturated monomers.
• NEUROTENSIN RECEPTOR LIGANDS
  申请人：3B Pharmaceuticals GmbH

  公开号：US20150299133A1

  公开（公告）日：2015-10-22

  The present invention is related to a compound of formula (I) wherein R 1 is selected from the group consisting of hydrogen, methyl and cyclopropylmethyl; AA-COOH is an amino acid selected from the group consisting of 2-amino-2-adamantane carboxylic acid, cyclohexylglycine and 9-amino-bicyclo[3.3.1]nonane-9-carboxylic acid; R 2 is selected from the group consisting of (C 1 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl, (C 3 -C 5 )cycloalkylmethyl, halogen, nitro and trifluoromethyl; ALK is (C 2 -C 5 )alkylidene; R 3 , R 4 and R 5 are each and independently selected from the group consisting of hydrogen and (C 1 -C 4 )alkyl under the proviso that one of R 3 , R 4 and R 5 is of the formula (II) wherein ALK′ is (C 2 -C 5 )alkylidene; R 6 is selected from the group consisting of hydrogen and (C 1 -C 4 )alkyl; and R 7 is selected from the group consisting of H and an Effector moiety; or a pharmacologically acceptable salt, solvate or hydrate thereof.